Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Haas, Naomi B, Dr, Manola, Judith, MS, Uzzo, Robert G, Prof, Flaherty, Keith T, MD, Wood, Christopher G, Prof, Kane, Christopher, Prof, Jewett, Michael, Prof, Dutcher, Janice P, Prof, Atkins, Michael B, Prof, Pins, Michael, Prof, Wilding, George, Prof, Cella, David, Prof, Wagner, Lynne, Prof, Matin, Surena, Prof, Kuzel, Timothy M, Prof, Sexton, Wade J, Prof, Wong, Yu-Ning, MD, Choueiri, Toni K, MD, Pili, Roberto, Prof, Puzanov, Igor, MD, Kohli, Manish, MD, Stadler, Walter, Prof, Carducci, Michael, Prof, Coomes, Robert, DiPaola, Robert S, Prof
Published in The Lancet (British edition) (14.05.2016)
Published in The Lancet (British edition) (14.05.2016)
Get full text
Journal Article
Update on the biology and management of renal cell carcinoma
Get full text
Journal Article
Book Review
Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma
RINI, Brian I, WILDING, George, HUDES, Gary, STADLER, Walter M, KIM, Sinil, TARAZI, Jamal, ROSBROOK, Brad, TRASK, Peter C, WOOD, Laura, DUTCHER, Janice P
Published in Journal of clinical oncology (20.09.2009)
Published in Journal of clinical oncology (20.09.2009)
Get full text
Journal Article
Recent developments in the treatment of renal cell carcinoma
Get full text
Book Review
Journal Article
Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
Correa, Andres F, Jegede, Opeyemi, Haas, Naomi B, Flaherty, Keith T, Pins, Michael R, Messing, Edward M, Manola, Judith, Wood, Christopher G, Kane, Christopher J, Jewett, Michael A S, Dutcher, Janice P, DiPaola, Robert S, Carducci, Michael A, Uzzo, Robert G
Published in Journal of clinical oncology (10.08.2019)
Published in Journal of clinical oncology (10.08.2019)
Get full text
Journal Article
Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
RINI, Brian I, HALABI, Susan, SMALL, Eric J, ROSENBERG, Jonathan E, STADLER, Walter M, VAENA, Daniel A, ARCHER, Laura, ATKINS, James N, PICUS, Joel, CZAYKOWSKI, Piotr, DUTCHER, Janice
Published in Journal of clinical oncology (01.05.2010)
Published in Journal of clinical oncology (01.05.2010)
Get full text
Journal Article
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
RINI, Brian I, HALABI, Susan, DUTCHER, Janice, SMALL, Eric J, ROSENBERG, Jonathan E, STADLER, Walter M, VAENA, Daniel A, OU, San-San, ARCHER, Laura, ATKINS, James N, PICUS, Joel, CZAYKOWSKI, Piotr
Published in Journal of clinical oncology (20.11.2008)
Published in Journal of clinical oncology (20.11.2008)
Get full text
Journal Article
Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis
Rini, Brian I, Garrett, May, Poland, Bill, Dutcher, Janice P, Rixe, Olivier, Wilding, George, Stadler, Walter M, Pithavala, Yazdi K, Kim, Sinil, Tarazi, Jamal, Motzer, Robert J
Published in Journal of clinical pharmacology (01.05.2013)
Published in Journal of clinical pharmacology (01.05.2013)
Get more information
Journal Article
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
Correa, Andres F., Jegede, Opeyemi A., Haas, Naomi B., Flaherty, Keith T., Pins, Michael R., Adeniran, Adebowale, Messing, Edward M., Manola, Judith, Wood, Christopher G., Kane, Christopher J., Jewett, Michael A.S., Dutcher, Janice P., DiPaola, Robert S., Carducci, Michael A., Uzzo, Robert G.
Published in European urology (01.07.2021)
Published in European urology (01.07.2021)
Get full text
Journal Article
BEST: A Randomized Phase II Study of Vascular Endothelial Growth Factor, RAF Kinase, and Mammalian Target of Rapamycin Combination Targeted Therapy With Bevacizumab, Sorafenib, and Temsirolimus in Advanced Renal Cell Carcinoma--A Trial of the ECOG-ACRIN Cancer Research Group (E2804)
Flaherty, Keith T, Manola, Judith B, Pins, Michael, McDermott, David F, Atkins, Michael B, Dutcher, Janice J, George, Daniel J, Margolin, Kim A, DiPaola, Robert S
Published in Journal of clinical oncology (20.07.2015)
Published in Journal of clinical oncology (20.07.2015)
Get full text
Journal Article
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial
Haas, Naomi B, Manola, Judith, Dutcher, Janice P, Flaherty, Keith T, Uzzo, Robert G, Atkins, Michael B, DiPaola, Robert S, Choueiri, Toni K
Published in JAMA oncology (01.09.2017)
Published in JAMA oncology (01.09.2017)
Get more information
Journal Article
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
Buchbinder, Elizabeth I, Dutcher, Janice P, Daniels, Gregory A, Curti, Brendan D, Patel, Sapna P, Holtan, Shernan G, Miletello, Gerald P, Fishman, Mayer N, Gonzalez, Rene, Clark, Joseph I, Richart, John M, Lao, Christopher D, Tykodi, Scott S, Silk, Ann W, McDermott, David F
Published in Journal for immunotherapy of cancer (18.02.2019)
Published in Journal for immunotherapy of cancer (18.02.2019)
Get full text
Journal Article
Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus
Maroto, Jose Pablo, Hudes, Gary, Dutcher, Janice P, Logan, Theodore F, White, Charles S, Krygowski, Mizue, Cincotta, Maria, Shapiro, Mark, Duran, Ignacio, Berkenblit, Anna
Published in Journal of clinical oncology (01.05.2011)
Published in Journal of clinical oncology (01.05.2011)
Get full text
Journal Article
The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma
McDermott, David F, Cheng, Su-Chun, Signoretti, Sabina, Margolin, Kim A, Clark, Joseph I, Sosman, Jeffrey A, Dutcher, Janice P, Logan, Theodore F, Curti, Brendan D, Ernstoff, Marc S, Appleman, Leonard, Wong, Michael K K, Khushalani, Nikhil I, Oleksowicz, Leslie, Vaishampayan, Ulka N, Mier, James W, Panka, David J, Bhatt, Rupal S, Bailey, Alexandra S, Leibovich, Bradley C, Kwon, Eugene D, Kabbinavar, Fairooz F, Belldegrun, Arie S, Figlin, Robert A, Pantuck, Allan J, Regan, Meredith M, Atkins, Michael B
Published in Clinical cancer research (01.02.2015)
Published in Clinical cancer research (01.02.2015)
Get full text
Journal Article
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
Stadler, Walter M., Figlin, Robert A., McDermott, David F., Dutcher, Janice P., Knox, Jennifer J., Miller, Wilson H., Hainsworth, John D., Henderson, Charles A., George, Jeffrey R., Hajdenberg, Julio, Kindwall‐Keller, Tamila L., Ernstoff, Marc S., Drabkin, Harry A., Curti, Brendan D., Chu, Luis, Ryan, Christopher W., Hotte, Sebastien J., Xia, Chenghua, Cupit, Lisa, Bukowski, Ronald M.
Published in Cancer (01.03.2010)
Published in Cancer (01.03.2010)
Get full text
Journal Article